Acuitas Therapeutics

Canada

1 August 2018 - 31 July 2019

Region: Global
Subject/journal group: All

The table to the right includes counts of all research outputs for Acuitas Therapeutics published between 1 August 2018 - 31 July 2019 which are tracked by the Nature Index.

Hover over the donut graph to view the FC output for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.

Note: Articles may be assigned to more than one subject area.

AC FC
2 0.38

Outputs by subject (FC)

Subject AC FC
Life Sciences 2 0.38
Physical Sciences 1 0.36

Top articles by Altmetric score in current window

Podocalyxin is required for maintaining blood-brain barrier function during acute inflammation

Proceedings of the National Academy of Sciences of the United States of America

2019-02-20

1 August 2018 - 31 July 2019

International vs. domestic collaboration by FC

  • 36.63% Domestic
  • 63.37% International

Note: Hover over the graph to view the percentage of collaboration.

Top 10 international collaborators by FC (4 total)

  • Acuitas Therapeutics, Canada
  • Foreign institution
  1. University of Pennsylvania (Penn), United States of America (USA) (0.71)
    0.36
    0.36
  2. Mount Sinai Health System (MSHS), United States of America (USA) (0.57)
    0.36
    0.21
  3. Penn Medicine, United States of America (USA) (0.50)
    0.36
    0.14
  4. BioNTech AG, Germany (0.43)
    0.36
    0.07

Note: Collaboration is determined by the fractional count (FC), which is listed in parentheses.

Return to institution outputs